Sobyanin: Moscow launches production of medicines for 13 types of cancer

The drug is intended for patients with melanoma, lung cancer and other dangerous diseases.

Technopolis Moscow, a resident of the Technopolis Moscow special economic zone, has started producing medicines for the treatment of 13 types of oncological diseases at once. Sergei Sobyanin announced this in his channel in the MAX messenger.

"The drug is intended for patients with melanoma, lung cancer and other dangerous diseases. The uniqueness of the drug is that it helps the human immune system to recognize and destroy cancer cells on its own," Sergei Sobyanin wrote.

The drug is included in the clinical recommendations of the Russian Ministry of Health and in the list of essential medicines. The medicine will be produced under an offset contract with the city. Moscow hospitals will start receiving it soon. Modern therapy will become more accessible to Muscovites, and supplies will be stable.

One of the largest biotech plants in the country is engaged in production. The company has already mastered the production of other drugs for leukemia, lymphoma and rheumatoid arthritis.

The status of a resident of a special economic zone gives the company tax benefits. She invests the money she has saved in new developments, of which there are more than 100 today.